Press Archive
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Reputable Ophthalmologist Vk Raju, MD, FRCS, FACS, will be Noted in The Leading Physicians of the World
Find an Eye MD near you!
- Details
Ophthotech announced that Genentech will join Novartis and split rights to pegpleranib (Fovista) for the treatment of wet AMD.
- Details
Allergan announced that its biodegradable sustained-release bimatoprost implant is comparable to daily topical bimatoprost.
Read more: Positive results for sustained-release bimatoprost implant
- Details
The U.S. FDA has granted orphan drug designation to AGTC’s gene therapy product candidate for the treatment of achromatopsia caused by mutations in the CNGA3 gene.
- Details
A randomized trial from DRCR.net has shown ranibizumab is as effective as panretinal photocoagulation in treating PDR, and better than laser in preserving patients’ peripheral and night vision.
- Details
Long-term response to anti-VEGF therapy in DME may be predicted after 3 injections at 12 weeks
Read more: Long-term response to anti-VEGF therapy for DME can be predicted by 12 Weeks
- Details
Pfizer today announced it reached a $160 billion deal to merge with Allergan.